Not So Different: A Podcast From The Center For Biosimilars
S4 Ep15: Not So Different: How Henlius is Making Its Mark on the Global Biosimilar Industry
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:35
- Mas informaciones
Informações:
Sinopsis
To hear more comments from Ping Cao, click here. To learn more about Henlius’ development plans, click here. To learn more about Henlius’ approval for their adalimumab biosimilar, click here. To learn more about PD-1 inhibitors, click here.
